NCT00824980View on ClinicalTrials.gov

Combined Inhibition of Dipeptidyl Peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/CD13) in the Treatment of Psoriasis

PHASE2UnknownINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Psoriasis
Interventions
DRUG

IP10.C8

IP10.C8 Gel 1%

Trial Locations (1)

8091

RECRUITING

University Hospital Zurich, Zurich

Sponsors
All Listed Sponsors
lead

Immune Technologies & Medicine GmbH

INDUSTRY

NCT00824980 - Combined Inhibition of Dipeptidyl Peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/CD13) in the Treatment of Psoriasis | Biotech Hunter | Biotech Hunter